News

/News
News 2018-06-05T05:00:59+00:00

Kintor received approval from Taiwan FDA for its ALK-1 and PD-1 joint clinical trial

November 15th, 2018|

Kintor Selected into 2018 Suzhou Unicorn Enterprises Breeding Program

November 11th, 2018|

Commencement of Kintor’s Suzhou R&D and Manufacturing Base

October 29th, 2018|

Researchers’ Conference of Proxalutamide’s Phase III Clinical Trial Held Successfully

May 6th, 2018|

Kintor Signed Global Strategic Cooperation Agreement with Predicine

March 3rd, 2018|

Kintor Raises RMB288 Million in Series C Financing to Accelerate its Anti-cancer Drug Development

January 11th, 2018|

Dr. Zhou Guohao Joined Kintor as Chief Medical Officer

August 30th, 2017|

Kintor Achieved New Milestone – Listed on New Third Board

December 16th, 2016|

TOT Biopharm Signed Production Cooperation Agreement with Kintor

December 2nd, 2016|

Kintor Selected to be the 10th Top 50 Investment-Worthy Companies 2015

December 2nd, 2015|

Kintor Raised USD 10 Million from Highlight Capital

July 16th, 2015|

Bear the Responsibility and Endure Loneliness | Dr. Tong Youzhi, Kintor

July 15th, 2015|